HomeChina

China

Chance Pharma Raises New Funding

Chance Pharma, a Hangzhou, China-based clinical-stage biotechnology company, raised an undisclosed amount in new funding. Backers included Heda Health Fund and Qihang Venture Capital. The...

Accropeutics Raises $12M in Series B Plus Financing

Accropeutics, a Suzhou, China-based clinical-stage biotechnology company that develops novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated diseases, raised...

Pulnovo Medical Closes $100M Series C

Pulnovo Medical, a Shanghai, China-based medtech company developing devices for pulmonary hypertension (PH) and heart failure (HF), raised $100M in Series C funding. The round...

Matwings Technology Raises Tens of Millions USD in Series A Funding

Shanghai Matwings Technology Co., Ltd., a global leader in AI-driven protein design, announced the completion of Series A funding rounds, raising tens of millions...

AusperBio Raises $73M in Series B Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a US and China based clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve...

Qi Biodesign Completes $75M in Total Funding

Qi Biodesign, a Beijing, China-based biotechnology company pioneering next-generation genome editing technologies, completed its Series A funding round. The Series A round was led...

Allink Biotherapeutics Raises $42M in Series A Financing

Allink Biotherapeutics, a Beijing, China-based clinical-stage biotechnology company providing new bispecific antibody and antibody-drug conjugate (ADC) therapeutics, raised $42M in Series A funding. The round...

C Ray Therapeutics Completes Over $100M Series A+ Financing

C Ray Therapeutics, a Chengdu, China-based enterprise in the field of radiopharmaceuticals, raised over $100M in Series A+ funding. The round was led by Shenzhen...

DeepRoute.ai Raises Major Series C1 Funding

DeepRoute.ai, Shenzhen, a China-based artificial intelligence company specializing in developing smart driving solutions, raised $100M in Series C1 funding. The round was led by OEM. The...

TenNor Raises Over RMB300M Financing

TenNor Therapeutics, a Suzhou, China-based clinical stage company dedicated to developing new therapies for infectious diseases, raised over RMB300M in Series E funding. Backers included...

LongBio Closes Series B2 Financing

LongBio, a Shanghai, China-based Phase III-stage biotech company focused on the R&D of antibody and fusion protein drugs for allergies and complement-mediated diseases, raised...

Ex-Co-Founder of Hamster Kombat Unleashes New Game-Changing Hard Fork: Meet Hamster Cash

Beijing, China, 23rd September 2024, Chainwire

THE DAILY NEWSLETTER - SIGNUP